Background: Door-to-balloon times strongly correlate with survival in patients referred for primary PCI. Guidelines have recommended that regions develop STEMI systems that quickly triage patients for primary PCI. We sought to evaluate door-to-balloon time amongst patients referred for primary PCI according to different referral pathways in the province of Ontario. Methods: We used the provincial primary PCI registry database developed by the Cardiac Care Network of Ontario Cath/PCI Working Group. We identified all patients who underwent primary PCI between July 2009 and December 2011 at 14 PCI capable centers. We evaluated time to reperfusion according to the following referral pathways: i) Field directly to the PCI center catheterization laboratory; ii) Field to the PCI center emergency department (ED); iii) Field to a non-PCI center ED; iv) Self-transport (Self-T) to a PCI capable center ED; v) Self-T to a non-PCI capable center ED. We excluded in-hospital patients presenting with STEMI on the wards. The primary endpoint was the first hospital door-to-balloon-time. Results: 6198 patients were referred for primary PCI. PCI was performed in 5678 patients. Data was available to calculate door-to-balloon times in 4763 patients. Amongst these patients, 63% were transported initially from the field, and 37% self-transported to the ED. The median door-to-balloon time with interquartile range for each referral pathway is shown in the table. Patients referred directly to the cath lab had significantly faster door-to-balloon times.
Conclusions: Prehospital triage is associated with very short door-to-balloon times when patients are transported directly to the catheterization laboratory. Self-transport leads to shorter door-to-balloon time when the pt presents at a PCI center. These results are relevant to regions planning to develop STEMI systems. 
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Impact of Multivessel Coronary Artery Disease With or Without a Concurrent Chronic Total Occlusion on Survival in Patients Treated With Rescue Angioplasty
Conclusions:
In the HORIZONS-AMI trial of patents with STEMI undergoing stent implantation, the relationship between ST and non-usage of DAPT was complex and varied overtime. It was strong during the 1-6 month timeframe, but not between 6 and 12 months. Hereafter, very late ST was associated with non-usage of aspirin but not of a thienopyridine.
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Coronary 
Conclusions:
The presence of significant CAD is a possible finding in a not trivial proportion of patients with TTC. Thus, when the the stenotic artery does not supply the dysfunctional myocardium, the presence of angiographically significant CAD should not be considered an exclusion criteria for TTC. 
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Incidence And Predictors Of 30 Days Mortality In Elderly Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Angioplasty
